<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>16</volume><submitter>Trajman A</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Shortened treatment regimens for tuberculosis are under development to improve treatment outcomes and reduce costs. We estimated potential savings from a societal perspective in Brazil following the introduction of a hypothetical four-month regimen for tuberculosis treatment.&lt;h4>Methods&lt;/h4>Data were gathered in ten randomly selected health facilities in Rio de Janeiro. Health service costs were estimated using an ingredient approach. Patient costs were estimated from a questionnaire administered to 126 patients. Costs per visits and per case treated were analysed according to the type of therapy: self-administered treatment (SAT), community- and facility-directly observed treatment (community-DOT, facility-DOT).&lt;h4>Results&lt;/h4>During the last 2 months of treatment, the </pubmed_abstract><journal>BMC health services research</journal><pagination>27</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4722708</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Shortened first-line TB treatment in Brazil: potential cost savings for patients and health services.</pubmed_title><pmcid>PMC4722708</pmcid><pubmed_authors>Calaca J</pubmed_authors><pubmed_authors>Trajman A</pubmed_authors><pubmed_authors>Belo M</pubmed_authors><pubmed_authors>Vassall A</pubmed_authors><pubmed_authors>Gaspar J</pubmed_authors><pubmed_authors>Brito RT</pubmed_authors><pubmed_authors>Wells WA</pubmed_authors><pubmed_authors>Dos Santos CM</pubmed_authors><pubmed_authors>Bastos ML</pubmed_authors><pubmed_authors>Dos Santos AM</pubmed_authors><pubmed_authors>Cobelens FG</pubmed_authors><pubmed_authors>Gomez GB</pubmed_authors></additional><is_claimable>false</is_claimable><name>Shortened first-line TB treatment in Brazil: potential cost savings for patients and health services.</name><description>&lt;h4>Background&lt;/h4>Shortened treatment regimens for tuberculosis are under development to improve treatment outcomes and reduce costs. We estimated potential savings from a societal perspective in Brazil following the introduction of a hypothetical four-month regimen for tuberculosis treatment.&lt;h4>Methods&lt;/h4>Data were gathered in ten randomly selected health facilities in Rio de Janeiro. Health service costs were estimated using an ingredient approach. Patient costs were estimated from a questionnaire administered to 126 patients. Costs per visits and per case treated were analysed according to the type of therapy: self-administered treatment (SAT), community- and facility-directly observed treatment (community-DOT, facility-DOT).&lt;h4>Results&lt;/h4>During the last 2 months of treatment, the </description><dates><release>2016-01-01T00:00:00Z</release><publication>2016 Jan</publication><modification>2026-07-15T22:16:22.136Z</modification><creation>2026-07-09T10:19:00.203Z</creation></dates><accession>S-EPMC4722708</accession><cross_references><pubmed>26800677</pubmed><doi>10.1186/s12913-016-1269-x</doi></cross_references></HashMap>